OBJECTIVES: To examine longitudinal changes in movement sequencing in prodromal Huntington's disease (HD) participants (795 prodromal HD; 225 controls) from the PREDICT-HD study. METHODS: Prodromal HD participants were tested over seven annual visits and were stratified into three groups (low, medium, high) based on their CAG-Age Product (CAP) score, which indicates likely increasing proximity to diagnosis. A cued movement sequence task assessed the impact of advance cueing on response initiation and execution via three levels of advance information. RESULTS: Compared to controls, all CAP groups showed longer initiation and movement times across all conditions at baseline, demonstrating a disease gradient for the majority of outcomes. Across all conditions, the high CAP group had the highest mean for baseline testing, but also demonstrated an increase in movement time across the study. For initiation time, the high CAP group showed the highest mean baseline time across all conditions, but also faster decreasing rates of change over time. CONCLUSIONS: With progress to diagnosis, participants may increasingly use compensatory strategies, as evidenced by faster initiation. However, this occurred in conjunction with slowed execution times, suggesting a decline in effectively accessing control processes required to translate movement into effective execution.
OBJECTIVES: To examine longitudinal changes in movement sequencing in prodromal Huntington's disease (HD) participants (795 prodromal HD; 225 controls) from the PREDICT-HD study. METHODS: Prodromal HDparticipants were tested over seven annual visits and were stratified into three groups (low, medium, high) based on their CAG-Age Product (CAP) score, which indicates likely increasing proximity to diagnosis. A cued movement sequence task assessed the impact of advance cueing on response initiation and execution via three levels of advance information. RESULTS: Compared to controls, all CAP groups showed longer initiation and movement times across all conditions at baseline, demonstrating a disease gradient for the majority of outcomes. Across all conditions, the high CAP group had the highest mean for baseline testing, but also demonstrated an increase in movement time across the study. For initiation time, the high CAP group showed the highest mean baseline time across all conditions, but also faster decreasing rates of change over time. CONCLUSIONS: With progress to diagnosis, participants may increasingly use compensatory strategies, as evidenced by faster initiation. However, this occurred in conjunction with slowed execution times, suggesting a decline in effectively accessing control processes required to translate movement into effective execution.
Authors: H Boecker; A Dagher; A O Ceballos-Baumann; R E Passingham; M Samuel; K J Friston; J Poline; C Dettmers; B Conrad; D J Brooks Journal: J Neurophysiol Date: 1998-02 Impact factor: 2.714
Authors: Andrew Feigin; Maria-Felice Ghilardi; Chaorui Huang; Yilong Ma; Maren Carbon; Mark Guttman; Jane S Paulsen; Claude P Ghez; David Eidelberg Journal: Ann Neurol Date: 2006-01 Impact factor: 10.422
Authors: B Giordani; S Berent; M J Boivin; J B Penney; S Lehtinen; D S Markel; Z Hollingsworth; G Butterbaugh; R D Hichwa; J F Gusella Journal: Arch Neurol Date: 1995-01
Authors: Deborah L Harrington; Jeffrey D Long; Sally Durgerian; Lyla Mourany; Katherine Koenig; Aaron Bonner-Jackson; Jane S Paulsen; Stephen M Rao Journal: Mov Disord Date: 2016-09-13 Impact factor: 10.338
Authors: Janessa O Carvalho; Jeffrey D Long; Holly J Westervelt; Megan M Smith; Jared M Bruce; Ji-In Kim; James A Mills; Jane S Paulsen Journal: J Clin Exp Neuropsychol Date: 2016 Impact factor: 2.475
Authors: Katherine A Koenig; Mark J Lowe; Deborah L Harrington; Jian Lin; Sally Durgerian; Lyla Mourany; Jane S Paulsen; Stephen M Rao Journal: Brain Connect Date: 2014-09
Authors: Deborah L Harrington; Mikail Rubinov; Sally Durgerian; Lyla Mourany; Christine Reece; Katherine Koenig; Ed Bullmore; Jeffrey D Long; Jane S Paulsen; Stephen M Rao Journal: Brain Date: 2015-06-09 Impact factor: 13.501
Authors: Lauren M Turner; David Jakabek; Fiona A Wilkes; Rodney J Croft; Andrew Churchyard; Mark Walterfang; Dennis Velakoulis; Jeffrey C L Looi; Nellie Georgiou-Karistianis; Deborah Apthorp Journal: Brain Behav Date: 2016-07-27 Impact factor: 2.708
Authors: Lora Minkova; Elisa Scheller; Jessica Peter; Ahmed Abdulkadir; Christoph P Kaller; Raymund A Roos; Alexandra Durr; Blair R Leavitt; Sarah J Tabrizi; Stefan Klöppel Journal: Front Hum Neurosci Date: 2015-11-25 Impact factor: 3.169